The association of Coronary Artery Disease and Female Androgenetic Alopecia in Thai population

Authors

  • Puangjai Varapornpipat Division of Cardiology, Department of Medicine, Phramongkutklao Hospital, Bangkok
  • Julphat Intarasupht Division of Cardiology, Department of Medicine, Phramongkutklao Hospital, Bangkok
  • Artit Nakakes Division of Cardiology, Department of Medicine, Phramongkutklao Hospital, Bangkok
  • Thoranis Chantrarat Division of Cardiology, Department of Medicine, Phramongkutklao Hospital, Bangkok

Abstract

Background: There have been many epidemiological studies exhibiting some evidence of association between coronary artery disease and female androgenetic alopecia, only few studies accentuate on the association of coronary angiography results and female androgenetic alopecia. Objectives: To determine the association of coronary angiography results and severity of female androgenic alopecia. Materials and Methods: Our study was a cross-sectional study include 203 female participants who underwent coronary angiography due to both emergency and non-emergency conditions. All of the participants were evaluated for the severity of the baldness according to Ludwig’ score1. Coronary angiography results were reported in standard protocols by interventional cardiologists. Results: There are 203 female patients, 60.4% (84 in 139) of the patients with female androgenetic alopecia and 56.3% (36 in 64) of the patients without alopecia had at least one significant coronary artery stenosis, the difference was not statistically significant in both univariate (odd ratio 1.12, 95% CI 0.74-1.69, p-value 0.573) and multivariate (odd ratio 0.93, 95% CI 0.49-1.77, p-value 0.833) analytic model. Conclusion: Our study revealed that there is no significant association between severity of baldness and result of coronary artery angiography in female androgenetic alopecia patients.

References

1. Ludwig E. Classification of the types of androgenetic alopecia (common baldness) occurring in the female sex. Br J Dermatol 1977;97:247–54.

2. Susan GC, Nixon JM, Carpenter RG, Evans DW. Factors discriminating men with coronary heart disease from healthy controls. Br Heart J 1972;34:458-64.

3. Yamada T, Kazuo H, Hitomi U, Takashi K. Male pattern baldness and its association with coronary heart disease: a meta-analysis. BMJ Open 2013; 3.

4. Su LH, Chen LS, Lin SC, Chen HH. Association of androgenetic alopecia with mortality from diabetes mellitus and heart disease. JAMA Dermatol. 2013;149:601-6.

5. Mansouri P, Mortazavi M, Eslami M, Mazinani M. Androgenetic alopecia and coronary artery disease in women. Dermatology Online J 2015; 11: 2.

6. Schnor P, Nyboe J, Lange P, Jensen G. Longevity and gray hair, baldness, facial wrinkles, and arcus senilis in 13,000 men and women: the Copenhagen City Heart Study. J Gerontol A BiolSci Med Sci 1998; 53:347-50.

7. Ford ES, Freedman DS, Byers T. Baldness and ischemic heart disease in a national sample of men. Am J Epidemiol 1996;143:651-7.

8. Mirić D, Fabijanić D, Giunio L, et al. Dermatological indicators of coronary risk: a case-control study. Int J Cardiol 1998;67:251-5.

9. Lotufo PA, Chae CU, Ajani UA, Hennekens CH, Manson JE. Male pattern baldness and coronary heart disease: the Physicians' Health Study. Arch Intern Med 2000; 160: 165-71.

Downloads

Published

2018-12-06

How to Cite

Varapornpipat, P., Intarasupht, J., Nakakes, A., & Chantrarat, T. (2018). The association of Coronary Artery Disease and Female Androgenetic Alopecia in Thai population. Thai Journal of Dermatology, 33(2), 153–160. Retrieved from https://he02.tci-thaijo.org/index.php/TJD/article/view/159228

Issue

Vol. 33 No. 2 (2017): April - June

Section

Original articles

License

เนื้อหาและข้อมูลในบทความที่ลงตีพิมพ์ในวารสารโรคผิวหนัง ถือเป็นข้อคิดเห็นและความรับผิดชอบของผู้เขียนบทความโดยตรงซึ่งกองบรรณาธิการวารสาร ไม่จำเป็นต้องเห็นด้วย หรือร่วมรับผิดชอบใดๆ

บทความ ข้อมูล เนื้อหา รูปภาพ ฯลฯ ที่ได้รับการตีพิมพ์ในวารสารโรคผิวหนัง ถือเป็นลิขสิทธิ์ของวารสารฯ หากบุคคลหรือหน่วยงานใดต้องการนำทั้งหมดหรือส่วนหนึ่งส่วนใดไปเผยแพร่ต่อหรือเพื่อกระทำการใดๆ จะต้องได้รับอนุญาตเป็นลายลักอักษรจากบรรณาธิการวารสารโรคผิวหนังก่อนเท่านั้น